EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement

Lisa Sandmann iD, Julius F M Egge iD, Anja Tiede iD, Alena F Ehrenbauer, Martin A Kabelitz, Hannah Rieland, Jim B Mauz, Bernhard C Meyer, Heiner Wedemeyer iD, Karin Weissenborn, Benjamin Maasoumy iD

United European Gastroenterology Journal · 2025-09 · 13 (7) · 1171-1183

DOI: 10.1002/ueg2.70095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, online erschienen am 09.08.2025. Verfasst von Lisa Sandmann und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany. Hauptthemen laut MEDLINE: Ammonia, Hepatic Encephalopathy, Hypertension, Portal, Portasystemic Shunt, Transjugular Intrahepatic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Placement of a transjugular intrahepatic portosystemic shunt (TIPS) is an effective treatment for portal hypertension. Overt hepatic encephalopathy (oHE) is a complication after TIPS associated with increased morbidity. Elevated ratio of plasma ammonia (AMM) levels compared to the local upper limit of normal (ULN) has been associated with oHE, hepatic complications and increased mortality in patients with cirrhosis without TIPS. The role of AMM in risk stratification of post‐TIPS oHE is unclear.

Objective

To investigate the role of AMM in the prediction of oHE in patients receiving TIPS placement.

Methods

Patients with TIPS placement were recruited within a prospective observational study protocol with follow‐up (FU) visits at 1, 3, 6, and 12 months after TIPS. Post hoc analyses of AMM levels for the association with the primary (oHE) and secondary endpoints (hepatic decompensation, infections, death/liver transplantation) during the first year after TIPS placement were performed.

Results

Of 188 patients with TIPS placement, 148 patients with available baseline AMM levels were included. During follow‐up, 37% (55/148) of patients developed oHE. In multivariable competing risk analysis, baseline AMM/ULN (HR 2.03 [CI 1.42–2.89], p = 0.001) and Freiburg index of post‐TIPS survival (FIPS) score (HR 1.52 [CI 1.03–2.24], p = 0.037) were independently associated with oHE. The published cut‐off AMM/ULN > 1.4 showed comparable results (HR 2.40 [CI 1.24–4.65], p = 0.01). AMM at FU1 was available in 100 patients, of whom 28% (28/100) developed oHE after FU1. In multivariable competing risk analysis, AMM/ULN (HR 5.48 [CI 2.37–12.67], p < 0.001), psychometric hepatic encephalopathy score (HR 0.86 [0.78–0.96], p = 0.005) and FIPS (HR 3.57 [CI 1.79–7.14], p < 0.001) at FU1 were independently associated with oHE after FU1. No significant association between AMM/ULN and the secondary endpoints was detected.

Conclusion

AMM levels before TIPS are independently associated with oHE after TIPS placement. AMM levels may serve as an additional marker for risk stratification of patients. Trial Registration Clinical trial number NCT04801290

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmmoniaHepatic EncephalopathyHypertension, PortalPortasystemic Shunt, Transjugular IntrahepaticPostoperative ComplicationsAdultAgedFemaleHumansMaleMiddle AgedFollow-Up StudiesLiver CirrhosisPredictive Value of TestsProspective StudiesRisk AssessmentRisk FactorsObservational Studies as Topic

Stichwörter der Autor:innen

Freiburg index of post‐TIPS survival (FIPS)liver cirrhosisovert hepatic encephalopathyplasma ammonia levelsportal hypertensionpost‐TIPS outcomestransjugular intrahepatic portosystemic shunt (TIPS)

Substanzen

Ammonia

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.
  • German Center for Infection Research (DZIF), Hannover, Germany.
  • Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany.

ORCID-Profile: Lisa Sandmann, Julius F M Egge, Anja Tiede, Heiner Wedemeyer, Benjamin Maasoumy

Zitieren

APA

Sandmann, L., Egge, J. F. M., Tiede, A., Ehrenbauer, A. F., Kabelitz, M. A., Rieland, H., Mauz, J. B., Meyer, B. C., Wedemeyer, H., Weissenborn, K., & Maasoumy, B. (2025). Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement. United European Gastroenterology Journal, 13(7), 1171-1183. https://doi.org/10.1002/ueg2.70095

Vancouver

Sandmann L, Egge JFM, Tiede A, Ehrenbauer AF, Kabelitz MA, Rieland H, et al. Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement. United European Gastroenterology Journal. 2025;13(7):1171-1183. doi:10.1002/ueg2.70095

BibTeX
@article{Sandmann2025,
  author = {Sandmann, Lisa and Egge, Julius F M and Tiede, Anja and Ehrenbauer, Alena F and Kabelitz, Martin A and Rieland, Hannah and Mauz, Jim B and Meyer, Bernhard C and Wedemeyer, Heiner and Weissenborn, Karin and Maasoumy, Benjamin},
  title = {Plasma Ammonia Levels Predict Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  volume = {13},
  number = {7},
  pages = {1171--1183},
  doi = {10.1002/ueg2.70095}
}
Kostenlos starten →